Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011-2018.

Autor: Njuma Libwea J; National Institute for Health and Welfare (THL), Helsinki, Finland.; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.; Expanded Programme on Immunization, Cameroon., Fletcher MA; Emerging Markets Medical Affairs, Vaccines, Pfizer, Inc, Paris, France., Koki Ndombo P; Expanded Programme on Immunization, Cameroon.; Mother & Child Hospital (MCH), Chantal Biya Foundation, Yaoundé, Cameroon., Boula A; Mother & Child Hospital (MCH), Chantal Biya Foundation, Yaoundé, Cameroon., Ashukem NT; Mother & Child Hospital (MCH), Chantal Biya Foundation, Yaoundé, Cameroon.; Ministry of Public Health, Yaoundé, Cameroon., Ngo Baleba M; Mother & Child Hospital (MCH), Chantal Biya Foundation, Yaoundé, Cameroon., Kingue Bebey RS; Mother & Child Hospital (MCH), Chantal Biya Foundation, Yaoundé, Cameroon., Nkolo Mviena EG; Mother & Child Hospital (MCH), Chantal Biya Foundation, Yaoundé, Cameroon., Tageube J; Mother & Child Hospital (MCH), Chantal Biya Foundation, Yaoundé, Cameroon., Kobela Mbollo M; Expanded Programme on Immunization, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon., Koulla-Shiro S; Ministry of Public Health, Yaoundé, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon., Madhi S; South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, Faculty of HealthSciences, University of the Witwatersrand, Johannesburg, South Africa., Njanpop-Lafourcade BM; Agence de Médicine Préventive (AMP), Paris, France., Mohammad A; Pfizer Vaccines Medical Development & Medical/Scientific Affairs, New York, New York, United States of America., Begier E; Pfizer Vaccines Medical Development & Medical/Scientific Affairs, New York, New York, United States of America., Southern J; Pfizer Vaccines Medical Development & Medical/Scientific Affairs, New York, New York, United States of America., Beavon R; Pfizer Vaccines Medical Development & Medical/Scientific Affairs, New York, New York, United States of America., Gessner B; Pfizer Vaccines Medical Development & Medical/Scientific Affairs, New York, New York, United States of America.

Publikováno v: PloS one [PLoS One] 2021 Apr 15; Vol. 16 (4), pp. e0250010. Date of Electronic Publication: 2021 Apr 15 (Print Publication: 2021).